351 related articles for article (PubMed ID: 19646687)
1. Feature extraction and dimensionality reduction for mass spectrometry data.
Liu Y
Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
[TBL] [Abstract][Full Text] [Related]
2. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
3. Support vector machine approach to separate control and breast cancer serum samples.
Pham TV; van de Wiel MA; Jimenez CR
Stat Appl Genet Mol Biol; 2008; 7(2):Article11. PubMed ID: 18312216
[TBL] [Abstract][Full Text] [Related]
4. Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.
Datta S
Stat Appl Genet Mol Biol; 2008; 7(2):Article7. PubMed ID: 18312221
[TBL] [Abstract][Full Text] [Related]
5. A wavelet-based data pre-processing analysis approach in mass spectrometry.
Li X; Li J; Yao X
Comput Biol Med; 2007 Apr; 37(4):509-16. PubMed ID: 16982045
[TBL] [Abstract][Full Text] [Related]
6. Multiscale processing of mass spectrometry data.
Randolph TW; Yasui Y
Biometrics; 2006 Jun; 62(2):589-97. PubMed ID: 16918924
[TBL] [Abstract][Full Text] [Related]
7. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
Barrett JH; Cairns DA
Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
[TBL] [Abstract][Full Text] [Related]
8. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.
Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; Cobelli C; Trajanoski Z
Bioinformatics; 2005 May; 21(10):2200-9. PubMed ID: 15784749
[TBL] [Abstract][Full Text] [Related]
10. A data review and re-assessment of ovarian cancer serum proteomic profiling.
Sorace JM; Zhan M
BMC Bioinformatics; 2003 Jun; 4():24. PubMed ID: 12795817
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
12. Bayesian model selection for mining mass spectrometry data.
Saksena A; Lucarelli D; Wang IJ
Neural Netw; 2005; 18(5-6):843-9. PubMed ID: 16139743
[TBL] [Abstract][Full Text] [Related]
13. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
14. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
15. Data mining techniques for cancer detection using serum proteomic profiling.
Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
[TBL] [Abstract][Full Text] [Related]
16. Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach.
Heidema AG; Nagelkerke N
Stat Appl Genet Mol Biol; 2008; 7(2):Article5. PubMed ID: 18312219
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers from mass spectrometry data using a "common" peak approach.
Fushiki T; Fujisawa H; Eguchi S
BMC Bioinformatics; 2006 Jul; 7():358. PubMed ID: 16869977
[TBL] [Abstract][Full Text] [Related]
18. Guilt-by-association feature selection: identifying biomarkers from proteomic profiles.
Shin H; Sheu B; Joseph M; Markey MK
J Biomed Inform; 2008 Feb; 41(1):124-36. PubMed ID: 17544868
[TBL] [Abstract][Full Text] [Related]
19. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
20. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
